SOCS3 divergent transcript (SOCS3-DT)

SOCS3 divergent transcript (SOCS3-DT) is a non-coding RNA gene, also termed a "divergent transcript," located at the SOCS3 genomic locus. Unlike the protein-coding SOCS3 gene, which regulates cytokine signaling and plays important roles in inflammation, immune function, and disease, SOCS3-DT does not code for a protein and its specific function is not well defined in the literature. There is no evidence that SOCS3-DT functions as a receptor, enzyme, transporter, or therapeutic target. Therefore, it should not be considered a traditional drug discovery target, and information about its role in drug interaction, mechanisms of action, or as a biomarker is not currently available. There may be confusion between the non-coding SOCS3-DT and the protein-coding SOCS3 gene, which is a bona fide therapeutic target involved in cytokine signaling and immune regulation. SOCS3 (Suppressor of cytokine signaling 3) is involved in pathways like JAK/STAT and is relevant in autoimmunity, cancer, and inflammation; however, SOCS3-DT refers specifically to the non-coding RNA and not the functional protein. No evidence suggests SOCS3-DT is a direct drug target. "SOCS3 divergent transcript" (SOCS3-DT) is a non-coding RNA, not a protein, not a receptor/enzyme/therapeutic target, and is typically not the intended drug target in biomedical research or drug discovery contexts. If your use case requires data on bona fide therapeutic targets, refer instead to the protein-coding "Suppressor of cytokine signaling 3 (SOCS3)" rather than "SOCS3-DT."

Other names

SOCS3-DTSOCS3 divergent transcript